
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp has demonstrated robust financial growth, achieving a compound annual growth rate (CAGR) of 16% since 2022, with notable increases driven by the recovery from the Change Healthcare cyberattack. The company displays strong performance in the ambulatory sector, with a current market share of 8%, and revenue growth in both high-value clients and subscription-based services indicates a healthy and expanding customer base. Additionally, channel partner fees, which have risen from 6.5% of revenue in 2022 to 7.1% in 1H25, suggest efficient market penetration strategies and underline the positive trajectory of the company's sales and marketing efforts.
Bears say
Waystar Holding Corp is experiencing a decline in key financial metrics, with capital expenditures as a percentage of revenue decreasing from previous years, indicating reduced investments that could hamper future growth. Revenue is anticipated to decrease sequentially in the third quarter, with fourth-quarter revenue expected to remain flat, reflecting concerns over the company's growth potential in a competitive market. Additionally, a significant drop in EBITDA and the implications of potential cybersecurity breaches further contribute to a negative outlook on the company's operational stability and client retention.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares